CAR T cell therapies for cancer
EHA Library. June C. 06/16/18; 219172 Topic: 4Aa Drug therapy including targeted drugs: mechanisms of action, pharmacology and drug resistance
Carl June
Carl June
Learning Objectives
• describe recent commercial approvals of CAR T cells and indications in lymphoma and leukemia,
• understand the distinctions between CAR T and TCR T cell therapies in emerging cancer therapies, and
• discuss the diagnosis and treatment of cytokine release syndrome (CRS),

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies